Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q2 2024 Earnings

9MayConfirmed

Q1 2023

Q2 2023

Q3 2023

Q2 2024

-0.22

-0.18

-0.14

-0.1

Details

Expected EPS

-0.145

Actual EPS

-0.1

Surprise EPS

0.04

Surprise Percent

+31.03%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.1 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.